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SUMMARY
Introduction Carbohydrate-deficient transferrin (CDT) has been suggested as one of alcohol abuse 
indicators having produced good results in forensic medicine for years.
Objective The aim of the study was to identify correlation between present methodology of alcohol 
abuse diagnosis at autopsy (macroscopic and microscopic findings) and CDT examination using the 
method of isoelectrofocusing (IEF) in polyacrylamide gel electrophoresis (PAGE). We also analyzed if 
the time interval between the moment of death and blood sample collection influences CDT findings.
Methods The method used for CDT analysis was IEF-PAGE. Sera of 49 males and 11 females aged 14-87 
years, average age 46.85±18.53, were used in this study. Control group consisted of five patients who 
died after medical treatment that lasted longer than 15 days, and five patients who started Disulfiram 
therapy in controlled hospital environment.
Results The results obtained in CDT examination in dead bodies’ sera showed sensitivity 59% and 
specificity 71%. A high incidence of falsely positive CDT result was noticed in liver failure and cirrhosis 
of non-alcoholic origin. CDT analysis is also possible to be done in samples collected postmortem up 
to 76 hours.
Conclusion In forensic medicine, the method of CDT determination is reliable for the diagnosis of alcohol 
abuse.
Keywords: alcoholism; carbohydrate-deficient transferrin (CDT); postmortem analysis; specificity; 
sensitivity
INTRODUCTION
Pathological changes caused by chronic alco-
hol abuse could considerably contribute to the 
cause of death and, on the other hand, changes 
in psychic sphere of an alcoholic could initiate 
accidents, homicides and suicides. Further-
more, withdrawal-related death is an entity that 
must be considered in cases of sudden death in 
the alcoholic [1, 2].
Changes related to chronic alcohol abuse 
occur either indirectly, due to alcohol abusers 
accidental falls (prominent body part injuries, 
chronic subdural hematoma, etc.) or directly 
due to toxic effect of alcohol as well as its highly 
reactive metabolite – acetaldehyde. In postmor-
tem diagnosis, the traditional methods used to 
identify alcoholism are autopsy findings, histo-
logical examination, medical records, heteroan-
amnestic data and blood alcohol concentrations. 
Alcohol related pathological changes are non-
specific and they could be found in numerous 
diseases. The same changes of the liver could 
be found in obesity, defects in fat metabolism, 
various kinds of hepatitis, hypoxic damage of 
hepatocytes, as well as toxic liver damage (chlo-
rophorm, arsenic, carbo-tetrachlorid, bacterial 
toxins, etc). Because of relatively non-specific 
pathological features, the difficulty in interpret-
ing blood alcohol levels for the purpose of an 
alcoholic and the lack of valid heteroanamnes-
tic records, it is necessary to establish a reliable 
biological marker for alcoholism identification 
in forensic practice [3].
Various biological markers such as methanol, 
phosphatidylethanol or fatty acid ethyl esters 
(FAEE) are found to be usable even on dead body 
material [4, 5]. Carbohydrate-deficient transfer-
rin (CDT) has been suggested as one of alcohol 
abuse indicators. Experience with CDT on dead 
body material is still humble [1, 2, 3, 6-9].
Serum trasfferin (Tf) occurs in at least seven 
isoforms: hexa-, penta-, tetra-, tri-, di-, mono- 
and asialo-trasferrin with different pIs (isoelec-
tronic points). In healthy person, the tetrasialo 
isoform accounts for about 80% of all circulat-
ing transferrin. The term CDT refers to iso-
forms with pIs≥5.7, i.e. asialo-Tf, monosialo-
Tf and disialo-Tf [8]. CDT increases to above 
normal values after more that 50-80 g (males) 
and 40 g (females) of alcohol daily intake and 
for the period longer than one and up to four 
weeks [4, 9-12]. After a few days, CDT values 
show a fast increase in the serum of the alcohol 
abuser, to decrease towards normal values after 
the discontinuation of alcohol intake [13, 14, 
15]. During abstinence, CDT serum concentra-
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and a half to two weeks [10, 15-18]. Raynard et al. [19] 
stated that the CDT half-time is 17±4 days.
Transferrin itself is glycoprotein stable at room tem-
perature, resistant to spontaneous and microbiological 
decomposition [20]. These features are desirable in fo-
rensic work because it enables analysis even after longer 
postmortem time.
OBJECTIVE
The aim of the study was to identify correlation between 
the present methodology of alcohol abuse in the diag-
nostics of dead bodies (macroscopic and microscopic 
findings) and CDT examination using the method of iso-
electrofocusing (IEF) in polyacrilamid gel electrophoresis 
(PAGE) with samples prepared by Rivanol according to 
Sagan [21]. At the same time, the application of IEF-PAGE 
method in forensic work was also evaluated. We exam-
ined if the time interval between the moment of death and 
blood sample collection influences CDT findings.
METHODS
In this study 60 dead bodies were initially examined at the 
Institute of Forensic Medicine of the Belgrade School of 
Medicine. Since the records of one case were not available, 
a total of 59 dead bodies were analyzed (47 males and 12 
females) aged 14-87 years.
For each subject the data about age, sex and alcohol 
abuse were collected as heteroanamnestic data from the 
closest relative, or from medical records and/or police re-
ports. For 10 of 57 subjects it was proven that they have 
not consumed alcohol during past 15 days. This group was 
assigned as a control group and included five patients treat-
ed at the Emergency Center due to trauma, and who died 
after medical treatment that lasted longer than 15 days, 
but were without pathoanatomic findings or anamnestic 
alcohol abuse data, and five patients who started Disulfiram 
therapy in controlled, hospital environment.
The cases were subjected to postmortem macroscopic 
and microscopic analysis with a special attention to the 
changes specific for alcoholism such as fatty liver, cirrhosis 
or hepatitis, atrophy and fibrosis of the pancreas, brain 
atrophy and fibrosis and hypertrophy of the heart [1].
For measurement of alcohol and CDT concentration, 
a total of 57 blood samples were drawn from the femoral 
vein during autopsy. Alcoholemia was established using 
the standard method of gas chromatography. The sera were 
derived by centrifugation in a very short period of time 
after collecting (up to 1 hour), then stored at -20oC. CDT 
concentration was analyzed by IEF-PAGE. It is well known 
that by using IEF (as well as capillary electrophoresis and 
HPLC), the fractions of asialo- and monosialo-transferin 
(Tf) are not identified in the serum of healthy subjects. 
This makes this technique adequate for CDT analysis [8].
Transferrin standard was made of serum pool of blood 
donors.
The data obtained were analyzed by SPSS software (av-
erage values, mediana, modus, χ2), while specificity and 
sensitivity were used for evaluating the model.
RESULTS
Fifty-nine subjects were included in the study with com-
plete data (47 male and 12 female), of the average age 
46.85±18.53 years; the youngest was 14 and the oldest 87. 
The average age of males and females was 47.96±18.81 and 
42.05±17.51, respectively (t=1.016; p>0.10).
In 38 cases blood samples were collected in the interval 
shorter than 36 hours postmortem, while 19 blood sam-
ples were collected after that period (the longest interval 
was 76 hours). In 24 analyzed cases CDT values were posi-
tive; in 18 cases up to 36 hours postmortem and in 6 cases 
after 36 hours. There was no significant difference between 
these groups (χ2=1.29, p>05).
In 22 of 31 subjects for whom it was undoubtedly stated 
that they had not consumed alcohol in the last 15 days of 
life CDT was not found. CDT was found in 14 of 26 sub-
jects who had consumed alcohol in the last 15 days of life 
(χ2=5.342, p>05) (Table 1). This shows that the presence 
of CDT in the analyzed sample was not accidental but was 
the result of drinking habits. According to these results, it 
is concluded that the sensitivity of CDT analysis was 59%, 
and specificity 71%.
The presence of alcohol was found in 10 subjects; al-
coholemia was above 1‰ in three subjects (which means 
that they must have taken over 70 g of alcohol) while CDT 
was positive. All this allows the conclusion that they were 
chronic alcoholics. In three of seven other subjects who had 
alcoholemia lower than 1‰, CDT was also positive.
In our analyzed sample, 12 subjects had severe liver dis-
ease and in eight subjects CDT was positive (three subjects 
were drunk having 1-2.55‰ of alcohol).




Control group  
(n=10)




CDT positive 0 9 14
Liver disease autopsy 0 0 3
Increased blood alcohol  
concentration of over 1‰ 0 0 3
n – number of subjects
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DISCUSSION
To evaluate CDT analysis values better, it was necessary 
to determine if the patients had consumed alcohol in the 
past 15 days. The knowledge of this was important in the 
study, as half-life of CDT is 15 days and its significant con-
centrations in circulation could not be expected after that 
period of time [10, 15, 16, 17, 19]. In all cases with medical 
treatment longer that 15 days (based on Emergency Center 
records of patients’ histories), these data were valid. The 
problem appeared with those died at the spot (except for 
ten cases of acute drunkenness) thus, in all others, we used 
heteroanemnestic data regarding alcohol consumption and 
drinking habits.
In the literature, we have found that valid CDT results 
are obtained 36-72 hours postmortem [2, 3, 6, 7, 22, 23]. 
Our results are coherent with the data of transferrin re-
sistance to spontaneous and bacterial decomposition that 
makes it adequate for alcohol detection in dead bodies 
even when the interval from the moment of death up to 
blood samples collection is longer. Some blood samples 
drawn from dead bodies showed a lower or higher level 
of hemolysis. However, hemoglobin does not disturb the 
identification of CDT focused in further pH area gel.
We have to point out that it was a hard task to obtain 
valid data on the following: if the subject had consumed 
alcohol within 15 days prior to death on the spot or after 
the survival time shorter than 15 days. Cases, where we 
could not obtain valid data of drinking habits on the basis 
of heteroanamnestic data, were grouped as those who had 
not consumed alcohol in the past 15 days. Thus, the ob-
tained values of specificity and sensitivity can be regarded 
as the possible lowest values. The analysis of the obtained 
results led to the conclusion that CDT analysis on dead 
body material is the valid diagnostic procedure in alcohol 
abuse determination.
It can be found in the literature that CDT values are not 
in strong correlation with the quantity of alcohol intake. 
Grouping of the samples according to alcohol content are 
based on literature knowledge of transferrin change and 
CDT occurrence due to 50-80 g of alcohol daily intake 
during at least a week. At the same time, the same quantity 
of alcohol causes alcoholemia a little above 1‰ when al-
cohol is taken within a short period of time [4, 10, 11, 12]. 
The presence of CDT along with alcoholemia under 1‰ 
proves that those persons were chronic alcoholics [9, 24].
Severe diseases of the liver (cirrhosis, hepatitis B and 
C) influence CDT concentration according to the dis-
ease stage [4, 16, 17]. CDT rises more often in early stage 
of alcoholic liver disease when transferrin synthesis is 
high, while in further stages, CDT reduces below normal 
values correlating the reduction of the number of func-
tional hepatocites [16]. A high incidence of falsely posi-
tive CDT result has been noticed in liver failure and cir-
rhosis of non-alcoholic origin [13, 15, 25]. Our analysis 
confirmed this, because eight subjects of 12 with severe 
liver disease were CDT positive but three were with high 
alcoholemia.
CONCLUSION
The results obtained in CDT examination in the sera of 
dead bodies (sensitivity 59% and specificity 71%) make the 
method of CDT determination reliable for the diagnosis 
of alcohol abuse in forensic medicine. CDT analysis is also 
possible to be performed in samples collected postmortem 
up to 76 hours.
NOTE
This paperwork is a part of PhD dissertation of the first au-
thor “The molecule variants of the carbohydrate-deficient 
transferrin as a marker of alcohol abuse”, defended at the 
School of Medicine, University of Belgrade.
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КРАТАК САДРЖАЈ
Увод По след њих го ди на тран сфе рин с не до стат ком угље-
них хи дра та (енгл. car bohydra te-de fi ci ent tran sfer rin – CDT) 
је дан је од мар ке ра зло у по тре бе ал ко хо ла ко ји је по ка зао 
нај бо ље ре зул та те у суд ској ме ди ци ни.
Циљ ра да Циљ сту ди је је био да се од ре ди ко ре ла ци ја из ме-
ђу ак ту ел не ме то до ло ги је ди јаг но зе зло у по тре бе ал ко хо ла 
на пост мор тал ном ма те ри ја лу (ма кро скоп ски и ми кро скоп-
ски на лаз) и од ре ђи ва ња CDT ко ри шће њем ме то де исо е лек-
тро фо ку си ра ња (енгл. iso e lec tric fo cu sing – IEF) у по ли а кри ла-
мид ном ге лу (енгл. polyacryla mi de gel elec trop ho re sis – PA GE). 
Утвр ђи ва но је да ли ин тер вал из ме ђу вре ме на смр ти и узи-
ма ња узо ра ка за CDT ана ли зу ути че на на лаз CDT.
Ме то де ра да За ана ли зу CDT ко ри шће на је ме то да IEF-PA GE. 
За сту ди ју су ана ли зи ра ни се ру ми 49 му шка ра ца и 11 же-
на про сеч не ста ро сти од 46,85±18,53 го ди на (рас пон 14–87 
го ди на). Кон трол ну гру пу чи ни ло је пет па ци је на та ко ји су 
умр ли на кон бол нич ког ле че ња ко је је тра ја ло ду же од 15 
да на и пет па ци је на та код ко јих је у кон тро ли са ним бол нич-
ким усло ви ма по че ло ле че ње ди сул фи ра мом.
Ре зул та ти До би је ни ре зул та ти по ка зу ју да ова ме то да ана-
ли зе CDT на пост мор тал ном ма те ри ја лу има сен зи тив ност 
од 59% и спе ци фич ност од 71%. Ви со ка уче ста лост ла жно 
по зи тив них ре зул та та утвр ђе на је код обо ље ња је тре и ци-
ро зе не ал ко хол ног по ре кла. Ана ли зу CDT је мо гу ће ра ди ти 
и из узо ра ка узе тих до 76 са ти на кон смр ти.
За кљу чак У суд ско ме ди цин ској прак си ова ме то да ана ли-
зе CDT мо же се ко ри сти ти за ди јаг но сти ко ва ње хро нич не 
зло у по тре бе ал ко хо ла.
Кључ не ре чи: ал ко хо ли зам; тран сфе рин с не до стат ком 
угље них хи дра та (CDT); пост мор тал на ана ли за; спе ци фич-
ност; сензитивност
Форензички аспекти постморталне анализе трансферина с недостатком  
угљених хидрата као маркера злоупотребе алкохола
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